Skip to main content
Gilead Sciences, Inc. (GILD)
NASDAQ: GILD · Real-Time Price · USD
88.63
+0.88 (1.00%)
At close: Nov 20, 2024, 4:00 PM
88.40
-0.23 (-0.26%)
Pre-market: Nov 21, 2024, 5:09 AM EST

Gilead Sciences Revenue

Gilead Sciences had revenue of $7.55B in the quarter ending September 30, 2024, with 7.02% growth. This brings the company's revenue in the last twelve months to $28.30B, up 3.31% year-over-year. In the year 2023, Gilead Sciences had annual revenue of $27.12B, down -0.60%.

Revenue (ttm)
$28.30B
Revenue Growth
+3.31%
P/S Ratio
3.90
Revenue / Employee
$1,572,167
Employees
18,000
Market Cap
110.46B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202327.12B-165.00M-0.60%
Dec 31, 202227.28B-24.00M-0.09%
Dec 31, 202127.31B2.62B10.60%
Dec 31, 202024.69B2.24B9.98%
Dec 31, 201922.45B322.00M1.46%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
The Cigna Group 229.75B
Elevance Health 174.02B
HCA Healthcare 69.62B
Pfizer 59.38B
Sanofi 54.03B
Bristol-Myers Squibb Company 47.44B
Medtronic 33.00B
Boston Scientific 15.91B
Revenue Rankings

GILD News

More News